首页|基于网络药理和分子对接探讨莪术-三棱药对治疗卵巢癌的作用机制

基于网络药理和分子对接探讨莪术-三棱药对治疗卵巢癌的作用机制

扫码查看
目的 探索莪术-三棱药对治疗卵巢癌的有效活性成分与分子生物学机制.方法 通过HERB及PubChem数据库检索并筛选出莪术及三棱的有效活性成分和相应的作用靶点;运用Therapeutic Targets、OMIM及GeneCard等数据库检索卵巢癌的疾病靶点.运用Cytoscape 3.9.0软件绘制药物-成分-靶点网络图,采用STRING数据库及Cy-toscape 3.9.0构建PPI网络图,进而使用Cytoscape中MCODE插件筛选出排名前10的核心靶点;使用R 4.2.2对作用靶点进行GO及KEGG通路富集分析;最后使用Auto Dock Vina等软件进行分子对接,验证核心成分与核心靶点的相互作用.结果 筛选出了 72种活性成分、760个作用靶点,莪术-三棱药对与卵巢癌共同靶基因有617个.核心成分为多梗白菜菊素、天人菊内酯、大花旋覆花素、山奈酚,PPI网络揭示了其主要的靶点,包括MAPK1、MAPK3、JAK1、JAK3、STAT3、MAP2K1、IL6、TYK2、KRAS以及SRC.KEGG富集分析显示共涉及186条通路,根据P<0.05提取与卵巢癌关联紧密的30条通路,主要包括cAMP信号通路、癌症中的蛋白聚糖通路、PI3K-AKT信号通路等.分子对接结果表明,活性成分与核心靶点之间展现出良好的结合亲和性.结论 三棱及莪术药对在卵巢癌的综合治疗方面具有多成分、多靶点及多通路的特征,为该药对在临床中的应用提供了信息支撑.
Mechanism of Sparganii Rhizoma-Curcumae Rhizoma herbal pair in anti-ovarian cancer:insights from network pharmacology and molecular docking
Objective To explore the effective active ingredients and molecular biological mechanism un-derlying the therapeutic effect of the Sparganii Rhizoma-Curcumae Rhizoma herbal pair in ovarian cancer treat-ment.Methods The active constituents and their corresponding targets of Sparganii Rhizoma-Curcumae Rhi-zoma were retrieved from the HERB and PubChem databases.Therapeutic Targets,OMIM,GeneCard and other databases were used to search the disease targets of ovarian cancer.Cytoscape 3.9.0 software was used to draw drug-ingredient-target network diagrams,STRING database and Cytoscape 3.9.0 were used to build PPI network diagram,and then MCODE plug-in in Cytoscape was used to screen out the top 10 core targets.GO and KEGG pathway enrichment analyses were performed for the targets using R 4.2.2.Finally,molecular doc-king with software such as Auto Dock Vina was conducted to validate the interaction between core components and core targets.Results A total of 72 active components and 760 targets were screened.Six hundred and seventeen common target genes were identified between Sparganii Rhizoma-Curcumae Rhizoma and ovarian cancer.The core components included dihydrohelenalin,gaillardinactone,brevicornin britanin and kaempferol.The PPI network revealed key targets,including MAPK1,MAPK3,JAK1,JAK3,STAT3,MAP2K1,IL6,TYK2,KRAS and SRC.KEGG enrichment analysis showed a total of 186 pathways involved,and 30 path-ways closely associated with ovarian cancer were extracted according to P<0.05,mainly including cAMP sig-naling pathway,proteoglycan pathway in cancer,and PI3K-AKT signaling pathway.The molecular docking results showed that the active ingredients showed good binding affinity with the core targets.Conclusion The Sparganii Rhizoma-Curcumae Rhizoma herbal pair exhibits the characteristics of multi-component,multi-target and multi-pathway in the comprehensive treatment of ovarian cancer,providing valuable insights for its clinical application.

ovarian cancerCurcumae RhizomaSparganii Rhizomanetwork pharmacologymolecular docking

刘曾晶、张蝶、蒙秋霞、王慧丰、胡艳玲

展开 >

广西医科大学信息与管理学院,广西 南宁 530022

广西医科大学再生医学与医用生物资源开发应用省部共建协同创新中心,广西 南宁 530022

广西医科大学基础医学院,广西 南宁 530022

广西医科大学生命科学研究院,广西 南宁 530022

广西医科大学基因组与个性化医学研究中心,广西 南宁 530022

展开 >

卵巢癌 莪术 三棱 网络药理 分子对接

广西医科大学青年科学基金

GXMUYSF202307

2024

右江民族医学院学报
右江民族医学院

右江民族医学院学报

影响因子:0.708
ISSN:1001-5817
年,卷(期):2024.46(2)
  • 25